Colin Love - 15 Oct 2021 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role
Chief Operating Officer
Signature
/s/ Jean Franchi, attorney-in-fact
Issuer symbol
REPL
Transactions as of
15 Oct 2021
Net transactions value
-$901,891
Form type
4
Filing time
19 Oct 2021, 21:01:32 UTC
Previous filing
17 Sep 2021
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REPL Common Stock Sale $68,552 -2,200 -0.28% $31.16 773,609 15 Oct 2021 Direct F1, F2
transaction REPL Common Stock Sale $457,348 -15,089 -2% $30.31 758,520 15 Oct 2021 Direct F1, F3
transaction REPL Common Stock Sale $375,991 -12,711 -1.7% $29.58 745,809 18 Oct 2021 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
F2 The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.90 to $31.72. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.97 to $30.69. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.32 to $29.96. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 Following the sales reported on this Form 4, the reporting person continues to beneficially own 745,809 shares of the Issuer's common stock. The reporting person also holds options to acquire 503,578 shares of the Issuer's common stock, 323,448 of which are exercisable as of the date hereof.